Stock data
Inovio Pharmaceuticals, Inc. (INO)
Inovio Pharmaceuticals, Inc. (INO) reported revenue of US$0.07M and net income of -US$84.95M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.07M | — | -US$86.82M | -US$84.95M | — |
| 2024 | US$0.22M | — | -US$112.40M | -US$107.25M | — |
| 2023 | US$0.83M | — | -US$143.94M | -US$135.12M | — |
| 2022 | US$10.26M | — | -US$267.57M | -US$279.82M | — |
| 2021 | US$1.77M | — | -US$301.22M | -US$303.66M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$6.01M | — |
| 2026-03-31 | US$0.00M | -US$19.68M | — |
| 2025-12-31 | US$0.00M | US$3.76M | — |
| 2025-09-30 | US$0.00M | -US$45.50M | — |
| 2025-06-30 | US$0.00M | -US$23.52M | — |
| 2025-03-31 | US$0.07M | -US$19.69M | — |
| 2024-12-31 | US$0.12M | -US$19.38M | — |
| 2024-09-30 | US$0.00M | -US$25.17M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.